Femoropopliteal reconstruction with 'KemAngioprotez' biological prosthesis

Burkov N.N.; Kazantsev A.N.; Anufriev A.I.; Danilovich A.I.; Smirnov K.V.; Lider R.Yu.; Bayandin M.S.; Evtushenko A.V.

doi:https://doi.org/10.17116/kardio20201301129

Burkov N.N.

Kemerovo Cardiologic Dispensary, Kemerovo, Russia

Kazantsev A.N.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

SPIN RSCI: 8396-1845
Scopus AuthorID: 57196122083
ORCID: 0000-0002-1115-609X

Anufriev A.I.

FGBU NII KPSSZ SO RAMN, Kemerovo

Danilovich A.I.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Smirnov K.V.

Altai Regional Children’s Clinical Hospital, Barnaul, Russia

Lider R.Yu.

Kemerovo State Medical University of Ministry of Health of Russia, Kemerovo, Russia

Bayandin M.S.

Kemerovo State Medical University of the Ministry of Health of the Russian Federation, Kemerovo, Russia

Evtushenko A.V.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Femoropopliteal reconstruction with 'KemAngioprotez' biological prosthesis

Authors:

Burkov N.N., Kazantsev A.N., Anufriev A.I., Danilovich A.I., Smirnov K.V., Lider R.Yu., Bayandin M.S., Evtushenko A.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(1): 29‑35

DOI: 10.17116/kardio20201301129

Read: 3577 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Burkov NN, Kazantsev AN, Anufriev AI, et al. . Femoropopliteal reconstruction with 'KemAngioprotez' biological prosthesis. Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(1):29‑35. (In Russ.)
https://doi.org/10.17116/kardio20201301129

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Objective. To analyze in-hospital results of femoropopliteal bypass/replacement using diepoxy-treated biological prosthesis. Material and methods. There were 259 procedures of femoropopliteal replacement and 56 bypass surgeries in patients with atherosclerotic lesion of the lower limb arteries for the period 2002—2016. Diepoxy-treated biological prosthesis was used as a conduit. Inclusion criteria were indications for femoropopliteal bypass/replacement and no need for cerebral and myocardial revascularization. Exclusion criteria were critical lower limb ischemia, severe concomitant diseases limiting postoperative follow-up. Results. The most common postoperative complication was lymphorrhea (n=21, 6.7%). Anastomotic leakage due to eruption of the ligature occurred in 4 (1.1%) patients that required additional sutures. One (0.3%) patient died from hypertensive crisis complicated by hemorrhagic stroke. Early prosthesis thrombosis developed in 10 (3.2%) patients that required urgent redo revascularization (replacement — 2 (0.6%) cases, thrombectomy — 3 (1.0%) cases, prosthetic-autovenous bypass below the knee-joint fissure — 5 (1.6%) patients). Thrombosis was caused by detachment of intima within anastomotic zone in 5 (1.6%) cases, underestimation of peripheral circulation (popliteal artery stenosis) — in 5 (1.6%) patients. Conclusion. Diepoxy-treated biological prosthesis is safe and effective for reconstruction of lower limb arteries. The most common postoperative complications are conduit thrombosis and lymphorrhea. However, incidence of these events is quite low (less than 7%).

Keywords:

femoropopliteal replacement

femoropopliteal bypass surgery

biological prosthesis

thrombosis of prosthesis

lymphorrhea

in-hospital results

Authors:

Burkov N.N.

Kemerovo Cardiologic Dispensary, Kemerovo, Russia

Kazantsev A.N.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

SPIN RSCI: 8396-1845
Scopus AuthorID: 57196122083
ORCID: 0000-0002-1115-609X

Anufriev A.I.

FGBU NII KPSSZ SO RAMN, Kemerovo

Danilovich A.I.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Smirnov K.V.

Altai Regional Children’s Clinical Hospital, Barnaul, Russia

Lider R.Yu.

Kemerovo State Medical University of Ministry of Health of Russia, Kemerovo, Russia

Bayandin M.S.

Kemerovo State Medical University of the Ministry of Health of the Russian Federation, Kemerovo, Russia

Evtushenko A.V.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Close metadata

References:

Van der Vijver-Coppen RJ, ‘t Mannetje YW, Menting TP, Lardenoije JW, Reijnen MP. Treating complex femoropopliteal lesions. J Cardiovasc Surg (Torino). 2018 Apr;59(2):158-163. https://doi.org/10.23736/S0021-9509.18.10374-0
Ambler GK, Twine CP. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev. 2018 Feb 11;2(2):CD001487. https://doi.org/10.1002/14651858.CD001487.pub3
Piffaretti G, Dorigo W, Castelli P, Pratesi C, Pulli R; PROPATEN Italian Registry Group. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass. J Vasc Surg. 2018 May;67(5):1463-1471.e1. https://doi.org/10.1016/j.jvs.2017.09.017
Sukovatykh BS, Sidorov DV, Belikov LN, Bolomatov NV. Comparative efficacy of an autovenous graft with damaged valves and a biological prosthesis in the femoral-popliteal position in the treatment of critical lower limb ischemia. Bulletin of the N. I. Pirogov National Medical and Surgical Center. 2016;11(3):71-75. (In Russ.)
Sukovatykh BS, Belikov LN, Sukovatykh MB, Sidorov DV. Choosing a method of femoral-popliteal bypass surgery below the fissure of the knee joint. Annals of surgery. 2016.21(5):312-320. (In Russ.)
Burkov NN, Kazantsev AN, Tarasov RS, Anufriev AI, Barbarash LS. Results of reconstructive interventions on the aortic femoral segment in patients with multifocal atherosclerosis. Surgery. 2018;5:13-18 (In Russ.)
Kashaev M.Sh., Yakupov A.R. Comparative evaluation of the results of surgical treatment of patients with atherosclerotic occlusion of the arteries of the femoral-popliteal segment in the early postoperative period. Medical Bulletin of Bashkortostan. 2018;13(6):69-72. (In Russ.)
Ivchenko A.O., Shvedov A.N., Ivchenko O.A., Savelyev I.O. The use of xenoprostheses reinforced with a titanium nickelide construction as a conduit for femoral-popliteal bypass surgery: a randomized controlled trial. Acta Biomedica Scientifica. 2017;2(6):114-117 (In Russ.)
Klinkert P, Post P, Breslau P, Bockel J. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27(4):357-362. https://doi.org/10.1016/j.ejvs.2003.12.027
Manduz S, Katrancioglu N, Ozker E, Dogan K. Early thrombosis in bovine mesenteric vein grafts after infrainguinal reconstruction. Int J Angiol. 2008;17(01):37-39.
Burkov NN, Kazantsev AN, Tarasov RS. Hospital outcomes of reconstructive interventions on the aortic-femoral segment in patients with multifocal atherosclerosis. Angiology and vascular surgery. 2018;24(2):139-145 (In Russ.)
Lv S, Wang Q, Zhao W, Han L, Wang Q, Batchu N, Ulain Q, Zou J, Sun C, Du J, Song Q, Li Q. A review of the postoperative lymphatic leakage. Oncotarget. 2017 Apr 20;8(40):69062-69075. https://doi.org/10.18632/oncotarget.17297
Obara A, Dziekiewicz MA, Maruszynski M, Witkowski A, Dąbrowski M, Chmielak Z. Lymphatic complications after vascular interventions. Wideochir Inne Tech Maloinwazyjne. 2014 Sep;9(3):420-426. https://doi.org/10.5114/wiitm.2014.43021
Choong AM, Alagaratnam S, Floyd D, Al-Dubaisi M, Loh A. How to locate and treat lymph leaks using patent blue V dye and Floseal. Ann Vasc Surg. 2014 Feb;28(2):495-497. https://doi.org/10.1016/j.avsg.2013.05.003
Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008 Sep;21(3):119-123. https://doi.org/10.1053/j.semvascsurg.2008.05.008
Exton RJ, Galland RB. Major groin complications following the use of synthetic grafts. Eur J Vasc Endovasc Surg. 20007 Aug;34(2): 188-190.
Ploeg AJ, Lardenoye JW, Peeters MP, Hamming JF, Breslau PJ. Wound complications at the groin after peripheral arterial surgery sparing the lymphatic tissue: a double-blind randomized clinical trial. Am J Surg. 2009 Jun;197(6):747-751. https://doi.org/10.1016/j.amjsurg.2008.04.014
Hamed O, Muck PE, Smith JM, Krallman K, Griffith NM. Use of vacuum-assisted closure (VAC) therapy in treating lymphatic complications after vascular procedures: new approach for lymphoceles. J Vasc Surg. 2008 Dec;48(6):1520-1523, 1523.e1-4. https://doi.org/10.1016/j.jvs.2008.07.059
Svensson S, Monsen C, Kölbel T, Acosta S. Predictors for outcome after vacuum assisted closure therapy of peri-vascular surgical site infections in the groin. Eur J Vasc Endovasc Surg. 2008 Jul;36(1):84-89. https://doi.org/10.1016/j.ejvs.2007.12.020
Töpel I, Betz T, Uhl C, Steinbauer MG. The impact of superficial femoral artery (SFA) occlusion on the outcome of proximal sartorius muscle transposition flaps in vascular surgery patients. J Vasc Surg. 2011 Apr;53(4):1014-1019. https://doi.org/10.1016/j.jvs.2010.11.047
Kaydorin AG, Tsyplyashchuk AV, Teterin GV, Kaydorina YuA, Savina YuS, Kochetkov ES. On the biological compatibility of basex prostheses with the recipient’s body. Circulatory pathology and cardiac surgery. 2011;1:21-23. (In Russ.)
Khorev NG, Konkova VO, Beller AV, Borovikov EV, Shojkhet YaN. Structural changes of a biological prosthesis. Angiology and vascular surgery. 2016;22(4):151-158. (In Russ.)
Barbarash LS, Ivanov SV, Zhuravleva IYu, Anufriev AI, Kazachek YaV, Kudryavtseva YuA, Zinets MG. 12 years of experience using bioprostheses to replace infra-anginal arteries. Angiology and vascular surgery. 2006;12(3):91-97. (In Russ.)
Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). Eur Heart J. 2018 Mar 1;39(9):763-816. https://doi.org/10.1093/eurheartj/ehx095
Pokrovsky AV, Golovyuk AL. The state of vascular surgery in the Russian Federation in 2018. Angiology and vascular surgery (appendix). 2019;25(2):29-33. (In Russ.)
Schneider PA. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication. J Vasc Surg. 2017 Sep;66(3):916-923. https://doi.org/10.1016/j.jvs.2017.05.110
Armstrong EJ, Singh S, Singh GD, Yeo KK, Ludder S, Westin G, et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv. 2013;82:1168-1174.
Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013;58:386-395.
Lammer J, Zeller Z, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versusbare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62:1320-1327.
Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al, and LEVANT 2 Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145-153.
Rocha-Singh K, Jaff MR, Crabtree TR, Bloch DA, Ansel G, and VIVA Physicians. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919.
Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54:1058-1066.